Minor Complication Rates Higher Among Black Patients After Bariatric Procedures
UNITED STATES, JUN 14 – Rapid weight loss from Ozempic or Wegovy causes loss of facial fat and collagen, leading to wrinkles and sunken eyes especially in adults over 65, experts say.
- On June 17, 2025, an American study presented at the ASMBS meeting showed surgery reduces psychiatric disorder risk more than weekly GLP-1 injections.
- The study compared mental health outcomes between patients who had metabolic and bariatric surgery and those using GLP-1 drugs like semaglutide or tirzepatide.
- Patients who underwent bariatric surgery experienced a weight reduction of approximately 58 pounds over a two-year period, which is about five times greater than the 12-pound loss seen in patients treated with GLP-1 medications during the same timeframe.
- ASMBS President Dr. Ann Rogers highlighted that although both sets of patients experience weight reduction, surgery for metabolic and bariatric conditions offers more lasting and significant results, while also stressing the importance of addressing mental health alongside physical treatment.
- The findings suggest embedding psychiatric screening and support in obesity treatments to reduce mental health burdens and call for further research on psychological impacts.
25 Articles
25 Articles
Bariatric surgery linked to lower risk of psychiatric disorders than GLP-1 drugs
People who have metabolic and bariatric surgery are significantly less likely to develop psychiatric disorders compared to those who take weekly injections of GLP-1 anti-obesity medications, according to a new study presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.
In a period of two years, bariatric surgery achieves a weight loss five times greater than GLP-1 receptor agonist drugs, such as Ozempic or Mounjaro. This is what has been shown by a real-life study that has just been presented at the Congress of the American Society of Bariatric and Metabolic Surgery (Asmbs) in Washington. The work, directed by NYU Langone Health, compared the results obtained with manga gastrectomy and gastric bypass versus in…
Daily Journal
Study suggests surgery more effective than Ozempic to lose weight
Researchers found after bariatric procedures, patients lost an average of 58 pounds after two years, compared to 12 pounds for patients who received a GLP-1 prescription.
Losing weight can help rehabilitate the habits of everyone at home, but it also brings new challenges When Amy Kane started taking Mounjaro in 2022, he expected to lose weight — what actually happened, with a loss of more than 77 pounds. What Kane, a 36-year-old creator in Chicago, did not expect the effects on his health were infectious. Shortly after he started using the medicine, his husband and his children became more healthy — and then the…
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
